Definium Therapeutics reported positive topline Phase 3 Panorama results for DT120 ODT in generalized anxiety disorder. The readout follows Voyage and marks the company’s third positive Phase 3 trial, strengthening its GAD pipeline.
published
Definium Therapeutics reported positive topline Phase 3 Panorama results for DT120 ODT in generalized anxiety disorder. The readout follows Voyage and marks the company’s third positive Phase 3 trial, strengthening its GAD pipeline.
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.